Cholesterol Management: Understanding the 2018 Guideline

Course overview

RX/NP Objectives: 1. Compare and contrast the 2013 and 2018 ACC/AHA cholesterol guidelines; list key similarities and differences. 2. Summarize the terms "primary prevention" and "secondary prevention" as it pertains to cardiovascular disease. Describe the risk assessment calculators that should be used for each patient to calculate the risk of developing atherosclerotic cardiovascular disease (ASCVD). 3. List the 4 statin benefit groups; recognize which patients would be classified into each group. Recommend a statin therapy based on the classification of a patient and/or whether they are part of a special population at risk for ASCVD. 4. Discuss guideline implementation strategies and provide patient counseling tips about statins and related muscle effects, liver dysfunction, and new-onset diabetes. Tech Objectives: 1.Describe the terms secondary and primary prevention as they relate to cardiovascular disease. List 3 key points from the 2018 ACC/AHA cholesterol management guideline. 2.Identify the statins and non-statins currently recommended for cholesterol management. List the three statin therapy intensity levels identified in the 2018 guideline. 3.Describe the major side effects that are seen with statins.